What is MANOVA

Neuropsychological abnormalities, as well as behavioural and psychological characteristics, are being examined in patients in order to determine the prevalence of cognitive impairment and other neurovascular risk factors, including prior strokes. The green light has been given by the institution's human ethics committee for this investigation. In order to conduct the study, the researchers used experimental clinical research techniques. Seventy-five stroke patients ranging in age from 20-70 were the focus of this study. All patients in the hospital had daily clinical examinations and were able to identify the underlying causes of their strokes. The NIMHANS Neuropsychological Battery was administered to all patients between one and six months after the onset of their stroke symptoms.